Does blue-light therapy effectively and safely treat seasonal and non-seasonal major depressive disorder (MDD) compared to active and inactive control conditions?
Bright Light Therapy Lamp, a systematic review and meta-analysis (Can J Psychiatry 2022, PMID 35522196) — a meta-analysis found no evidence for blue-light efficacy compared to inactive conditions (mean difference = 2.43; 95% CI, -1.28 to 6.14) and no differences compared to active conditions (mean difference = -0.11; 95% CI, -2.38 to 2.16).
Source: Can J Psychiatry 2022, PMID 35522196 ↗ · Research map · How Magellan grades evidence · evidence confidence: high
Can J Psychiatry · 2022 · PMID 35522196 · DOI 10.1177/07067437221097903
Blue-light therapy's effectiveness for seasonal and non-seasonal depression remains unproven based on current evidence.
The question
Does blue-light therapy effectively and safely treat seasonal and non-seasonal major depressive disorder (MDD) compared to active and inactive control conditions?
What they tested
The study aimed to determine the efficacy and safety of blue-light therapy for seasonal and non-seasonal MDD.
How they did it
A systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted by searching Web of Science, EMBASE, Medline, PsycInfo, and Clinicaltrials.gov. Data was extracted by two independent reviewers. The primary outcome was the difference in endpoint scores on the SIGH-SAD or SIGH-ADS, while secondary outcomes included response (≥ 50% improvement) and remission rates.
What they found
Nine RCTs (347 participants) were included, with seven focusing on seasonal MDD and two on non-seasonal MDD. A meta-analysis found no evidence for blue-light efficacy compared to inactive conditions (mean difference = 2.43; 95% CI, -1.28 to 6.14) and no differences compared to active conditions (mean difference = -0.11; 95% CI, -2.38 to 2.16). There were also no significant differences in response and remission rates. Blue-light therapy was generally well-tolerated.
What it means
The efficacy of blue-light therapy for treating seasonal and non-seasonal MDD is not yet proven.
Limitations
Future trials need to be of longer duration, include larger sample sizes, and standardize light therapy parameters more effectively.
The paper at a glance
| Title | Blue-Light Therapy for Seasonal and Non-Seasonal Depression: A Systematic Review and Meta-Analysis |
|---|---|
| Journal | Can J Psychiatry |
| Year | 2022 |
| PMID | 35522196 ↗ |
| DOI | 10.1177/07067437221097903 ↗ |
| Topic | Sleep, circadian rhythm & stress |
Read the source: PubMed record (authors, abstract, full citation) ↗ · Publisher via doi.org ↗
Where Magellan uses this paper
This citation sits behind the evidence grade on the pages below. Grades are set from the research and are independent of affiliate commissions.
Bright Light Therapy Lamp
Randomized controlled trials and meta-analyses indicate that bright light therapy reduces depressive symptoms in seasonal affective disorder and, as an adjunct, in nonseasonal depression — a 2024 JAMA Psychiatry meta-analysis found roughly doubled remission (40.7% vs 23.5%) and response (60.4% vs 38.6%) rates versus…
A bright light therapy lamp (light box) is a device that emits high-intensity, broad-spectrum white…
Research describes the compound or intervention studied. It is not a claim about any specific product.
Cite this page
These citations point at this summary. To cite the original paper with its full author list, use the PubMed record or doi.org.
Magellan Longevity. (2026). Does blue-light therapy effectively and safely treat seasonal and non-seasonal major depressive disorder (MDD) compared to active and inactive control conditions? [Plain-English summary of Can J Psychiatry 2022, PMID 35522196, DOI 10.1177/07067437221097903]. Magellan Longevity. https://magellanlongevity.com/study/d35522196.html@misc{magellan_d35522196,
title = {Does blue-light therapy effectively and safely treat seasonal and non-seasonal major depressive disorder (MDD) compared to active and inactive control conditions?},
author = {{Magellan Longevity}},
year = {2026},
howpublished = {\url{https://magellanlongevity.com/study/d35522196.html}},
note = {Plain-English summary of PubMed PMID 35522196; DOI 10.1177/07067437221097903; Can J Psychiatry 2022. Reviewed by Gabriel Radu, DO},
urldate = {2026-08-11}
}https://magellanlongevity.com/study/d35522196.htmlRelated studies in the Magellan library
- Efficacy of light therapy versus antidepressant drugs in major depressive episodesSleep Med Rev · 2019 · PMID 31600678
- Is bright light therapy (BLT) effective in treating seasonal affective disorder (SAD) in adults?Psychother Psychosom · 2019 · PMID 31574513
- Effect of Repeated Low-Level Red-Light Therapy for Myopia Control in ChildrenOphthalmology · 2022 · PMID 34863776
- Hair cortisol, perceived stress, and resilience as predictors of coronary arterial diseaseStress Health · 2021 · PMID 34652868
- What nutritional interventions, foods, beverages, and supplements can improve sleep quality…Nutrients · 2021 · PMID 34068512
- Does low-level transcutaneous stimulation of the auricular branch of the vagus nerve (tVNS)…JACC Clin Electrophysiol · 2023 · PMID 37999672
All 23 Magellan summaries on sleep, circadian rhythm & stress →
Prefer the interactive version? Open this summary in the Magellan app → · Browse all 314 study summaries →